Caption Management, LLC Eye Point Pharmaceuticals, Inc. Put Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$7.58 - $10.54 $5.3 Million - $7.37 Million	-699,400 Reduced 93.33%	50,000 $399,000
Q2 2024 Aug 14, 2024	BUY	$8.16 - $22.89 $5.44 Million - $15.3 Million	666,800 Added 807.26%	749,400 $6.52 Million
Q1 2024 May 15, 2024	SELL	$19.93 - $29.71 $298,950 - $445,650	-15,000 Reduced 15.37%	82,600 $1.71 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $285,500 - $1.21 Million	50,000 Added 105.04%	97,600 $2.26 Million
Q3 2023 Nov 14, 2023	BUY	$7.99 - $15.36 $380,324 - $731,136	47,600 New	47,600 $380,000
Q4 2021 Feb 11, 2022	BUY	$10.18 - $18.4 $1.82 Million - $3.29 Million	178,700 Added 439.07%	219,400 $2.68 Million
Q3 2021 Nov 12, 2021	BUY	$7.51 - $11.72 $305,657 - $477,004	40,700 New	40,700 $424,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $312M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.